Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLight Science Technologies Regulatory News (LST)

Share Price Information for Light Science Technologies (LST)

Share Price is delayed by 15 minutes
Get Live Data
1.80    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.20 (11.765%)
Market Cap: £17.71m
LST Live PriceLast checked at - London Stock Exchange

Intraday Light Science Technologies Share Chart

Director Dealing

24 May 2022 13:27

RNS Number : 6231M
Light Science Tech. Holdings PLC
24 May 2022
 

Light Science Technologies Holdings plc

("LSTH" or the "Company")

 

Director Dealing

 

Light Science Technologies Holdings plc (AIM: LST), the controlled environment agriculture technology and contract electronics manufacturing group, announces that Robert Naylor, Non-Executive Director, has transferred 850,000 ordinary shares of 1 penny each in the Company ("Ordinary Shares") from a nominee account to his SIPP account. The Ordinary Shares were transferred at a price of 12 pence each and remain beneficially owned by Robert Naylor.

 

Accordingly, Robert Naylor's total holding in the Company remains unchanged at 2,500,000 Ordinary Shares, representing approximately 1.4 per cent. of the Company's issued share capital.

 

For further information, please contact:

Light Science Technologies Holdings plc

 

www.lightsciencetechnologiesholdings.com

Simon Deacon, Chief Executive Officer

Jim Snooks, Chief Financial Officer

Andrew Hempsall, Chief Operating Officer

via Walbrook PR

 

Strand Hanson Limited (Nominated & Financial Adviser)

Tel: +44 (0) 20 7409 3494

Ritchie Balmer / James Harris / Rob Patrick

Turner Pope Investments (TPI) Ltd (Broker)

Tel: +44 (0) 20 3657 0050

James Pope / Andy Thacker

 

Walbrook PR Ltd (Media & Investor Relations)

Tel: +44 (0)20 7933 8780 or lst@walbrookpr.com

Nick Rome / Paul McManus

 

About Light Science Technologies Holdings plc (www.lightsciencetechnologiesholdings.com)

Light Science Technologies Holdings plc is the holding company of the Group's controlled environment agriculture ("CEA") division, Light Science Technologies Ltd ("Light Science Technologies"), and its contract electronics manufacturing ("CEM") division, UK Circuits and Electronics Solutions Limited ("UK Circuits").

 

Controlled Environment Agriculture

Light Science Technologies was founded in 2019 and is the Company's grow lights and sensor technology business, providing bespoke recipes and technologies tailored to customers' needs - with key targets including indoor, vertical, glasshouses, polytunnels and medicinal farming markets. The all-in-one CEA solution will include analysing customers' crop growing requirements to provide bespoke, low-energy and sustainable equipment.

 

Market drivers include food and water shortages in many parts of the world; growing global population; UK and other government policy encouraging sustainable and efficient growth methods; increased scrutiny of the effect of food production on climate change and the continuing transition away from processed foods. 

 

Contract Electronics Manufacturing

UK Circuits is the Company's CEM focussed division, with strong revenue and cash generation. The Group designs, procures, and manufactures high-quality CEM products, specialising in Printed Circuit Boards, which are used in a range of sectors including audio, automotive, electronics, gas detection, lighting, pest control, telecommunications and, more recently, the CEA market.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Robert Naylor

2

Reason for the notification

a)

Position/status

 

Non-Executive Director

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Light Science Technologies Holdings plc

b)

LEI

213800V9MWRRLVQ6EY56

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of 1 penny each

Identification code

GB00BNDQJN14

b)

Nature of the transaction

Purchase and sale of Ordinary Shares

c)

 

Price(s) and volume(s)

Price

Volume

12.000 pence sale

850,000

12.006 pence purchase

850,000

d)

 

Aggregated information

- Aggregated volume

N/A, single transaction

- Aggregate Value

e)

Date of the transaction

24 May 2022

f)

Place of the transaction

London

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBZLFLLELZBBB
Date   Source Headline
10th Jun 20264:54 pmRNSHolding(s) in Company
10th Jun 20267:00 amRNSManufacturing Partnership & Capacity Expansion
9th Jun 202610:14 amRNSHolding(s) in Company
5th Jun 20267:00 amRNSGrant of Share Options
22nd May 202612:37 pmRNSResult of AGM
11th May 20261:53 pmRNSHolding(s) in Company
7th May 20267:00 amRNSCEM Contract Win
6th May 20267:00 amRNS-RInvestor Evening
5th May 20267:00 amRNSFirst order as Injectaclad supplier
30th Apr 20267:00 amRNSTotal Voting Rights
24th Apr 20267:00 amRNSFinal Results, Analyst and Investor Presentations
17th Apr 20261:40 pmRNSHolding(s) in Company
17th Apr 20267:00 amRNSNotice of Results, Analyst Briefing, Investor Pres
16th Apr 20267:00 amRNSHolding(s) in Company
15th Apr 20264:32 pmRNSHolding(s) in Company
15th Apr 20262:44 pmRNSHolding(s) in Company
15th Apr 20262:42 pmRNSHolding(s) in Company
15th Apr 20267:00 amRNSCompletion of Acquisitions
14th Apr 20264:22 pmRNSHolding(s) in Company
14th Apr 20261:26 pmRNSHolding(s) in Company
14th Apr 202612:04 pmRNSHolding(s) in Company
9th Apr 202611:52 amRNSResult of General Meeting & Total Voting Rights
9th Apr 20268:05 amRNS-RBSR Strategic Plan: Positive Implications for PFP
31st Mar 20267:00 amRNSTotal Voting Rights
30th Mar 20267:00 amRNSAgTech Contract Win
20th Mar 20261:29 pmRNSHolding(s) in Company
18th Mar 20264:38 pmRNSHolding(s) in Company
17th Mar 20267:00 amRNSResult of Retail Offer
17th Mar 20267:00 amRNSResult of Retail Offer
11th Mar 20269:58 amRNSResult of Placing
11th Mar 20269:58 amRNSResult of Placing
11th Mar 20267:10 amRNSLaunch of Retail Offer
11th Mar 20267:10 amRNSLaunch of Retail Offer
11th Mar 20267:00 amRNSAcquisitions and Fundraise to raise up to £6.6m
11th Mar 20267:00 amRNSAcquisitions and Fundraise to raise up to £6.6m
3rd Nov 20251:00 pmRNS-RAgTech - UK Parliamentary Group Calls for Action
27th Oct 20257:00 amRNSAgTech Contract Win
15th Oct 20257:00 amRNS-RAgTech Update
29th Sep 20257:00 amRNS-RPFP Division Secures BSA Accreditation
25th Sep 20257:00 amRNSHolding(s) in Company
16th Sep 20257:00 amRNSHolding(s) in Company
26th Aug 20257:00 amRNSContract Wins
20th Aug 20255:46 pmRNSHolding(s) in Company
20th Aug 202512:13 pmRNSHolding(s) in Company
18th Aug 20252:32 pmRNSHolding(s) in Company
15th Aug 202511:16 amRNSHolding(s) in Company
15th Aug 20257:00 amRNSCEM Contract Wins
14th Aug 20254:30 pmRNSHolding(s) in Company
13th Aug 20257:00 amRNSHalf-year Report
5th Aug 20257:00 amRNSNotice of Results, Analyst Briefing, Investor Pres

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.